From 5b8541db2fd49fd56dd2501ded7fdce24225782a Mon Sep 17 00:00:00 2001 From: Richard Croker Date: Tue, 29 Aug 2023 14:39:21 +0100 Subject: [PATCH 1/4] Update lptrimipramine.json amended text --- .../measure_definitions/lptrimipramine.json | 35 +++++++++++++------ 1 file changed, 25 insertions(+), 10 deletions(-) diff --git a/openprescribing/measure_definitions/lptrimipramine.json b/openprescribing/measure_definitions/lptrimipramine.json index 487f583859..7be3c1d927 100644 --- a/openprescribing/measure_definitions/lptrimipramine.json +++ b/openprescribing/measure_definitions/lptrimipramine.json @@ -1,21 +1,28 @@ { "name": "NHS England Low Priority Treatment - trimipramine", - "title": [ - "Trimipramine cost per 1000 patients" - ], - "description": [ - "Cost of trimipramine per 1000 patients" - ], + "title": "Trimipramine cost per 1000 patients", + "description": "Cost of trimipramine per 1000 patients", "numerator_short": "Trimipramine cost (£)", "denominator_short": "1000 patients", "why_it_matters": [ - "Trimipramine is an older tricyclic antidepressant. The cost has increased significantly recently, ", - "and there are newer, cheaper alternatives are available, which are ", - " recommended by NICE in preference to tricyclic antidepressants. " + "

", + "NHS England guidance states:

", + "

The tricyclic antidepressant (TCA) trimipramine is significantly more expensive than other antidepressants.

", + "

NICE guidance on depression in adults recommends selective serotonin reuptake inhibitor (SSRI) antidepressants first line if are indicated as they have a more favourable risk-to-benefit ratio ", + "compared to TCAs. However, if a TCA is required, more cost-effective TCAs than trimipramine are available.

", + "

Due to the significant cost associated with trimipramine and the availability of alternative treatments, the joint clinical working group considered trimipramine suitable for inclusion in this guidance.

", + "

NHS England recommend that GPs:", + "

" ], "tags": [ "cost", "lowpriority", + "lowpriority_exceptions", "mentalhealth", "nice" ], @@ -27,5 +34,13 @@ "numerator_bnf_codes_filter": [ "0403010Y0 # Trimipramine Maleate" ], - "denominator_type": "list_size" + "denominator_type": "list_size", + "authored_by": "richard.croker@phc.ox.ac.uk", + "checked_by": "", + "date_reviewed": "2023-08-15", + "next_review": "2025-08-15", + "measure_complexity": "low", + "measure_type": "bnf_code", + "radar_exclude": false + } \ No newline at end of file From 6c4b6463362d236684e63e6e18dd5ba9433c00d8 Mon Sep 17 00:00:00 2001 From: Richard Croker Date: Tue, 5 Sep 2023 12:29:34 +0100 Subject: [PATCH 2/4] Update lptrimipramine.json amend title and hyperlink --- openprescribing/measure_definitions/lptrimipramine.json | 4 ++-- 1 file changed, 2 insertions(+), 2 deletions(-) diff --git a/openprescribing/measure_definitions/lptrimipramine.json b/openprescribing/measure_definitions/lptrimipramine.json index 7be3c1d927..b54bcc89a5 100644 --- a/openprescribing/measure_definitions/lptrimipramine.json +++ b/openprescribing/measure_definitions/lptrimipramine.json @@ -1,11 +1,11 @@ { - "name": "NHS England Low Priority Treatment - trimipramine", + "name": "Items which should not routinely be prescribed in primary care - trimipramine", "title": "Trimipramine cost per 1000 patients", "description": "Cost of trimipramine per 1000 patients", "numerator_short": "Trimipramine cost (£)", "denominator_short": "1000 patients", "why_it_matters": [ - "

", + "

", "NHS England guidance states:

", "

The tricyclic antidepressant (TCA) trimipramine is significantly more expensive than other antidepressants.

", "

NICE guidance on depression in adults recommends selective serotonin reuptake inhibitor (SSRI) antidepressants first line if are indicated as they have a more favourable risk-to-benefit ratio ", From b0bcc76a7552289dc5854fc3a0e08752537c6dc2 Mon Sep 17 00:00:00 2001 From: Richard Croker Date: Tue, 12 Sep 2023 16:15:18 +0100 Subject: [PATCH 3/4] Update lptrimipramine.json remove tag --- openprescribing/measure_definitions/lptrimipramine.json | 5 ++--- 1 file changed, 2 insertions(+), 3 deletions(-) diff --git a/openprescribing/measure_definitions/lptrimipramine.json b/openprescribing/measure_definitions/lptrimipramine.json index b54bcc89a5..e9811b3317 100644 --- a/openprescribing/measure_definitions/lptrimipramine.json +++ b/openprescribing/measure_definitions/lptrimipramine.json @@ -15,14 +15,13 @@ "

    ", "
  • Do not initiate.
    • ", "
  • Deprescribe in patients currently prescribed this medicine.
    • ", - "
  • Prescribe only if no other item or intervention is clinically appropriate..
    • ", - "
  • Prescribe only if no other item or intervention is available..
    • ", + "
  • Prescribe only if no other item or intervention is clinically appropriate.
    • ", + "
  • Prescribe only if no other item or intervention is available.
    • ", "
" ], "tags": [ "cost", "lowpriority", - "lowpriority_exceptions", "mentalhealth", "nice" ], From a98c5f245fcb23dd20d06ca5da4036f0151003a9 Mon Sep 17 00:00:00 2001 From: Andrew Brown <75492467+a-d-brown@users.noreply.github.com> Date: Mon, 18 Sep 2023 11:12:05 +0100 Subject: [PATCH 4/4] Update lptrimipramine.json --- openprescribing/measure_definitions/lptrimipramine.json | 6 +++--- 1 file changed, 3 insertions(+), 3 deletions(-) diff --git a/openprescribing/measure_definitions/lptrimipramine.json b/openprescribing/measure_definitions/lptrimipramine.json index e9811b3317..b6f3cd25ee 100644 --- a/openprescribing/measure_definitions/lptrimipramine.json +++ b/openprescribing/measure_definitions/lptrimipramine.json @@ -8,7 +8,7 @@ "

", "NHS England guidance states:

", "

The tricyclic antidepressant (TCA) trimipramine is significantly more expensive than other antidepressants.

", - "

NICE guidance on depression in adults recommends selective serotonin reuptake inhibitor (SSRI) antidepressants first line if are indicated as they have a more favourable risk-to-benefit ratio ", + "

NICE guidance on depression in adults recommends selective serotonin reuptake inhibitor (SSRI) antidepressants first line if indicated as they have a more favourable risk-to-benefit ratio ", "compared to TCAs. However, if a TCA is required, more cost-effective TCAs than trimipramine are available.

", "

Due to the significant cost associated with trimipramine and the availability of alternative treatments, the joint clinical working group considered trimipramine suitable for inclusion in this guidance.

", "

NHS England recommend that GPs:", @@ -35,11 +35,11 @@ ], "denominator_type": "list_size", "authored_by": "richard.croker@phc.ox.ac.uk", - "checked_by": "", + "checked_by": "andrew.brown@phc.ox.ac.uk", "date_reviewed": "2023-08-15", "next_review": "2025-08-15", "measure_complexity": "low", "measure_type": "bnf_code", "radar_exclude": false -} \ No newline at end of file +}